(Q47692829)

4 February 2018

title

Apolipoprotein E and multiple sclerosis: a biochemical and genetic investigation (English)

1 reference

4 February 2018

0 references

Gaillard O

1

1 reference

4 February 2018

Gervais A

2

1 reference

4 February 2018

Meillet D

3

1 reference

4 February 2018

Plassart E

4

1 reference

4 February 2018

Fontaine B

5

1 reference

4 February 2018

Lyon-Caen O

6

1 reference

4 February 2018

Delattre J

7

1 reference

4 February 2018

Schuller E

8

1 reference

4 February 2018

publication date

1 June 1998

1 reference

4 February 2018

Journal of the Neurological Sciences

published in

1 reference

4 February 2018

volume

158

1 reference

4 February 2018

issue

2

1 reference

4 February 2018

page(s)

180-186

1 reference

4 February 2018

A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900118-X

Clinical relevance of the quantification of apolipoprotein E in cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900118-X

Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900118-X

Immunochemical estimation of IgG and albumin in cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900118-X

The role of genetic factors in multiple sclerosis susceptibility.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900118-X

Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900118-X

Apolipoprotein E intrathecal synthesis is decreased in multiple sclerosis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900118-X

An enzyme-linked immunosorbent assay method to measure human apolipoprotein E levels using commercially available reagents: effect of apolipoprotein E polymorphism on serum apolipoprotein E concentration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900118-X

Apolipoprotein E is localized to the cytoplasm of human cortical neurons: a light and electron microscopic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900118-X

Brain expression of apolipoproteins E, J, and A-I in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900118-X

Apolipoprotein E in patients with dementia of the Alzheimer type and vascular dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900118-X

Apolipoprotein E (apoE) polymorphism and its influence on ApoE concentrations in the cerebrospinal fluid in Finnish patients with Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900118-X

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900118-X

Neurodegeneration in the central nervous system of apoE-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900118-X

Expression of apolipoprotein E by mouse brain astrocytes and its modulation by interferon-gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900118-X

Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900118-X

Cerebrospinal fluid concentrations of soluble amyloid beta-protein and apolipoprotein E in patients with Alzheimer's disease: correlations with amyloid load in the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900118-X

Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900118-X

Apolipoprotein E polymorphism and Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900118-X

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900118-X

Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900118-X

Apolipoproteins in human cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900118-X

Apo E genotypes in multiple sclerosis, Parkinson's disease, schwannomas and late-onset Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900118-X

Electroimmunodiffusion of IgG heavy chains in nanogram quantities with a carboxymethyl-cellulose-agarose gel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900118-X

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900118-X

Apolipoprotein E allele in Chamorros with amyotrophic lateral sclerosis/parkinsonism-dementia complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900118-X

Apoprotein E is synthesized and secreted by resident and thioglycollate-elicited macrophages but not by pyran copolymer- or bacillus Calmette-Guerin-activated macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900118-X

10.1016/S0022-510X(98)00118-X

7 January 2021

Identifiers

DOI

1 reference

4 February 2018

1 reference

4 February 2018